Atara Biotherapeutics said on Tuesday the U.S. health regulator had placed a clinical hold on its trials for cancer cell ...

Picking a member of the office's Narcotics & Money Laundering unit could signify a broader shift toward a focus on drug ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.

The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...

The newly FDA-approved nasal spray called Spravato is being manufactured by Johnson & Johnson's and is a standalone treatment ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The exclusion of coconut as a major food allergen eases trade barriers for coconut-based products in the US market, according to the Philippine Coconut Authority (PCA). This, after the US Food and ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...